STOCK TITAN

ZOOZ Strategy Ltd. Warrant (ZOOZW) Financials

ZOOZW NASDAQ
FY2025 annual
Revenue $247K -76.3% YoY
Net Income -$55.6M n/m YoY
EPS (Diluted) -$0.94 YoY not available
Free Cash Flow -$13.9M n/m YoY
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD FYE December

Newest figures come from the 20-F for FY2025, filed Mar 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the ZOOZW SEC filings page.

ZOOZ Strategy Ltd. Warrant (ZOOZW) reported $247K in revenue for fiscal year 2025, down 76.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ZOOZW FY2025

FY2025 shows a balance-sheet transformation funded externally, while the operating business shrank and its reported costs overwhelmed revenue.

The striking mismatch is between a net loss of $55.6M and operating cash flow of -$13.8M: earnings deteriorated far more than cash usage, so non-cash or non-operating effects likely drove much of the gap. Meanwhile, $154.5M of financing cash flow alongside -$122.0M of investing cash flow links the balance-sheet expansion to capital raised rather than operating cash generation.

Revenue fell 76.3% from FY2024 to $247K, while cost of revenue rose 103.7% to $3.1M. That combination indicates a contraction in activity paired with a much heavier cost burden, rather than ordinary operating leverage.

Assets expanded 854.8% to $122.6M, showing a fundamentally larger reported balance sheet. Liabilities were only 2.7% of assets and the current ratio was 9.9x, yet free cash flow remained -$13.9M; financial strength therefore comes from capitalization, not self-funded operations.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

ZOOZ Strategy Ltd. Warrant does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
3/8

ZOOZ Strategy Ltd. Warrant passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

ZOOZ Strategy Ltd. Warrant reported a net loss of $55.6M while operations used $13.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

ZOOZ Strategy Ltd. Warrant reported an operating loss of $53.1M against $160K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$247K
YoY-76.3%

ZOOZ Strategy Ltd. Warrant generated $247K in revenue in fiscal year 2025. This represents a decrease of 76.3% from the prior year.

EBITDA
-$52.8M
YoYn/m

ZOOZ Strategy Ltd. Warrant's EBITDA was -$52.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior year is not meaningful, because that figure was zero or negative.

Net Income
-$55.6M
YoYn/m

ZOOZ Strategy Ltd. Warrant reported a net loss of $55.6M in fiscal year 2025. The change from the prior year is not meaningful, because that figure was zero or negative.

EPS (Diluted)
-$0.94

ZOOZ Strategy Ltd. Warrant earned -$0.94 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$13.9M
YoYn/m

ZOOZ Strategy Ltd. Warrant recorded an outflow of $13.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. The change from the prior year is not meaningful, because that figure was zero or negative.

Cash & Debt
$27.0M
YoY+258.8%

ZOOZ Strategy Ltd. Warrant held $27.0M in cash as of fiscal year 2025; no long-term debt figure is on record for that period.

Shares Outstanding
162M

ZOOZ Strategy Ltd. Warrant had 162M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-46.6%
YoY+117.0pp

ZOOZ Strategy Ltd. Warrant's ROE was -46.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 117.0 percentage points from the prior year.

Gross Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$3.7M
YoY-26.1%

ZOOZ Strategy Ltd. Warrant invested $3.7M in research and development in fiscal year 2025. This represents a decrease of 26.1% from the prior year.

Capital Expenditures
$93K
YoY+38.8%

ZOOZ Strategy Ltd. Warrant invested $93K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 38.8% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

ZOOZW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZOOZW annual income statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Revenue$247K-76.3%$1.0M+36.3%$764K+16.5%$656KN/A
Cost of Revenue$3.1M+103.7%$1.5M-18.3%$1.9M+950.0%$178KN/A
Gross Profit-$2.9Mn/m-$486Kn/m-$1.1M-331.2%$478KN/A
R&D Expenses$3.7M-26.1%$5.1M-2.9%$5.2M+25.3%$4.2M+173.3%$1.5M
SG&A Expenses$16.2M+225.1%$5.0M-15.3%$5.9M+52.6%$3.9M+28.1%$3.0M
Operating Income-$53.1Mn/m-$10.5Mn/m-$12.2Mn/m-$8.2Mn/m-$4.5M
EBITDA-$52.8Mn/m-$10.2Mn/m-$12.0Mn/m-$8.1Mn/m-$4.5M
Interest Expense$160K-6.4%$171KN/AN/AN/A
Net Income-$55.6Mn/m-$11.0Mn/m-$11.8Mn/m-$7.8Mn/m-$4.6M
EPS (Basic)-$0.94-$1.09-$1.99-$1.51-$2.27
EPS (Diluted)-$0.94-$1.09-$1.99-$1.51-$2.27
Diluted Shares (Avg)59,29110,0705,9125M2M

Not reported in any period shown, so not listed: Income Tax.

ZOOZW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZOOZW annual balance sheet
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Total Assets$122.6M+854.8%$12.8M-4.7%$13.5M-47.0%$25.4MN/A
Current Assets$28.9M+171.3%$10.7M+3.7%$10.3M-55.2%$22.9MN/A
Cash & Equivalents$27.0M+258.8%$7.5M+12.9%$6.7M-67.6%$20.6MN/A
Short-Term Investments$0n/m$0n/m$0n/m$0N/A
InventoryN/A$2.3M-18.5%$2.8M+61.2%$1.8MN/A
Long-Term Investments$0n/m$0n/m$0n/m$0N/A
Total Liabilities$3.4M-45.0%$6.1M+42.7%$4.3M+2.8%$4.2MN/A
Current Liabilities$2.9M-43.5%$5.2M+59.6%$3.3M+11.4%$2.9MN/A
Non-Current Liabilities$432K-53.5%$929K-10.2%$1.0M-17.3%$1.3MN/A
Total Equity$119.2M+1674.3%$6.7M-26.9%$9.2M-56.8%$21.3M+706.0%$2.6M
Retained Earnings-$113.8Mn/m-$58.2Mn/m-$47.2Mn/m-$35.4MN/A

Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.

ZOOZW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZOOZW annual cash flow statement
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Operating Cash Flow-$13.8Mn/m-$9.9Mn/m-$12.2Mn/m-$10.5Mn/m-$6.1M
Depreciation & Amortization$364K-2.7%$374K+56.5%$239K+82.4%$131K+197.7%$44K
Stock-Based Compensation$6.7M+1716.0%$369Kn/m-$219Kn/m-$1.8Mn/m-$1.3M
Capital Expenditures$93K+38.8%$67K-95.1%$1.4M+173.0%$500K+67.8%$298K
Free Cash Flow-$13.9Mn/m-$10.0Mn/m-$13.6Mn/m-$11.0Mn/m-$6.4M
Investing Cash Flow-$122.0M-76847.2%$159Kn/m-$1.3Mn/m-$500Kn/m-$298K
Financing Cash Flow$154.5M+1340.6%$10.7MN/A$27.9M+264.6%$7.6M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

ZOOZW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

ZOOZW annual financial ratios
MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-F
Gross Margin-1159.5%-46.7%-144.6%72.9%N/A
Operating Margin-21510.5%-1012.1%-1598.3%-1250.3%N/A
Net Margin-22505.7%-1055.7%-1538.6%-1192.8%N/A
Return on Equity-46.6%+117.0pp-163.6%-35.7pp-127.9%-91.1pp-36.8%+136.8pp-173.7%
Return on Assets-45.4%+40.3pp-85.6%+1.6pp-87.2%-56.5pp-30.8%N/A
Current Ratio9.85+7.8x2.05-1.1x3.16-4.7x7.85N/A
Liabilities-to-Equity0.03-0.9x0.91+0.4x0.47+0.3x0.20N/A
Asset Turnover0.00-0.1x0.080.0x0.060.0x0.03N/A
FCF Margin-5618.2%-960.1%-1779.7%-1684.0%N/A

Not reported in any period shown, so not listed: Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin, FCF Margin.

Frequently Asked Questions

What is ZOOZ Strategy Ltd. Warrant's annual revenue?

ZOOZ Strategy Ltd. Warrant (ZOOZW) reported $247K in total revenue for fiscal year 2025. This represents a -76.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is ZOOZ Strategy Ltd. Warrant's revenue growing?

ZOOZ Strategy Ltd. Warrant (ZOOZW) revenue declined by 76.3% year-over-year, from $1.0M to $247K in fiscal year 2025.

Is ZOOZ Strategy Ltd. Warrant profitable?

No, ZOOZ Strategy Ltd. Warrant (ZOOZW) reported a net loss of $55.6M in fiscal year 2025.

ZOOZ Strategy Ltd. Warrant (ZOOZW) reported diluted earnings per share of -$0.94 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had EBITDA of -$52.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

ZOOZ Strategy Ltd. Warrant (ZOOZW) has a return on equity of -46.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

ZOOZ Strategy Ltd. Warrant (ZOOZW) recorded an outflow of $13.9M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

ZOOZ Strategy Ltd. Warrant (ZOOZW) recorded an outflow of $13.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had $122.6M in total assets as of fiscal year 2025, including both current and long-term assets.

ZOOZ Strategy Ltd. Warrant (ZOOZW) invested $93K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

ZOOZ Strategy Ltd. Warrant (ZOOZW) invested $3.7M in research and development during fiscal year 2025.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had 162M shares outstanding as of fiscal year 2025.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had a current ratio of 9.85 as of fiscal year 2025, which is generally considered healthy.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had a liabilities-to-equity ratio of 0.03 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

ZOOZ Strategy Ltd. Warrant (ZOOZW) had a return on assets of -45.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

ZOOZ Strategy Ltd. Warrant (ZOOZW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

ZOOZ Strategy Ltd. Warrant (ZOOZW) reported a net loss of $55.6M while operations used $13.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

ZOOZ Strategy Ltd. Warrant (ZOOZW) reported an operating loss of $53.1M against $160K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top